List view / Grid view
13 November 2013 | By Boehringer Ingelheim
"Our extensive studies have demonstrated that tiotropium Respimat® has the potential to be an effective new treatment..."
13 November 2013 | By Biogen Idec
Phase 3 study showed potential for once- or twice-weekly prophylactic dosing regimens...
13 November 2013 | By Johnson & Johnson
Janssen Biotech, Inc. [“Janssen”] today announced the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules for the treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.1 This indication is based on overall response rate (ORR). An improvement in survival or…
13 November 2013 | By Abbott
The Abbott Fund provide $450,000 in grants and healthcare products to help people affected by super typhoon...
12 November 2013 | By kdm communications
Genia Geo has chosen Tecan’s HID EVOlution™ system as part of its comprehensive forensic identification services for governments around the world...
With advances in medical treatments and an aging population, the demand for donated blood continues, as fewer people are becoming lifelong donors. 1In an effort to raise awareness about blood donation and encourage young adults to become repeat blood donors, Music Saves Lives® and Abbott are announcing a special opportunity…
11 November 2013 | By Janssen Therapeutics EMEA
HCV is a major problem in the EMEA region, where an estimated 15 million people are living with the disease...
11 November 2013 | By Novartis
Spain-based Grifols to acquire Novartis blood transfusion diagnostics unit for USD 1.675 billion...
11 November 2013 | By Boehringer Ingelheim
Boehringer Ingelheim announces clinical experience with its angiotensin II receptor blocker (ARB) has reached 50 million patient-years of real world experience...
11 November 2013 | By AstraZeneca
Zoladex has been manufactured at AstraZeneca’s Macclesfield plant for over 25 years, supplying the medicine to more than one hundred markets around the world...
9 November 2013 | By Merck
“Patients in this study who took the investigational Timothy grass sublingual allergy immunotherapy tablet showed a significant improvement in common allergy symptoms..."
8 November 2013 | By Pfizer
The primary endpoint of the study was not achieved as there was not a statistically significant difference in renal function improvement...
7 November 2013 | By Amgen
Innovative program - Amgen Biotech Experience - brings real-world biotechnology lab experience to students...
7 November 2013 | By Abbott
Similac is trying to meet that resource need with the launch of StrongMoms Español, a free program that provides Hispanic moms relevant, Spanish-language resources...
6 November 2013 | By kdm communications limited
Quotient Clinical – the pioneer of Translational Pharmaceutics™ – will be showcasing the benefits of its unique, integrated approach to formulation development...
